AAAAAA
Results:
1-13
|
Results: 13
Authors:
Schopf, M
Beltrami, I
Boccadoro, M
Kramer, D
Citation: M. Schopf et al., ECDM (Electro Chemical Discharge Machining), a new method for trueing and dressing of metal-bonded diamond grinding tools, CIRP ANN-M, 50(1), 2001, pp. 125-128
Authors:
Tarella, C
Cuttica, A
Caracciolo, D
Zallio, F
Ricca, I
Bergui, L
Gavarotti, P
Marinone, C
Pagano, M
Rossi, G
de Crescenzo, A
Salomone, A
Ladetto, M
Boccadoro, M
Pileri, A
Citation: C. Tarella et al., High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developments, ANN HEMATOL, 80, 2001, pp. B123-B126
Authors:
Palumbo, A
Giaccone, L
Bertola, A
Pregno, P
Bringhen, S
Rus, C
Triolo, S
Gallo, E
Pileri, A
Boccadoro, M
Citation: A. Palumbo et al., Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma, HAEMATOLOG, 86(4), 2001, pp. 399-403
Authors:
Mariani, S
Coscia, M
Even, J
Peola, S
Foglietta, M
Boccadoro, M
Sbaiz, L
Restagno, G
Pileri, A
Massaia, H
Citation: S. Mariani et al., Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion, BR J HAEM, 113(4), 2001, pp. 1051-1059
Authors:
Palumbo, A
Triolo, S
Baldini, L
Callea, V
Capaldi, A
De Stefano, V
Grasso, M
Liberati, M
Lotesoriere, C
Marceno, R
Marmont, F
Musto, P
Petrucci, MT
Spriano, M
Pileri, A
Boccadoro, M
Citation: A. Palumbo et al., Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients, HAEMATOLOG, 85(5), 2000, pp. 508-513
Authors:
Boccadoro, M
Omede, P
Dominietto, A
Palumbo, A
Bringhen, S
Giaretta, F
Ortolano, B
Triolo, S
Pileri, A
Citation: M. Boccadoro et al., Multiple myeloma: the number of reinfused plasma cells does not influence outcome of patients treated with intensified chemotherapy and PBPC support, BONE MAR TR, 25(1), 2000, pp. 25-29
Authors:
Besostri, B
Beggiato, E
Bianchi, A
Mariani, S
Coscia, M
Peola, S
Foglietta, M
Boccadoro, M
Pileri, A
Moretta, L
Massaia, M
Citation: B. Besostri et al., Increased expression of non-functional killer inhibitory receptor CD94 in CD8(+) cells of myeloma patients, BR J HAEM, 109(1), 2000, pp. 46-53
Authors:
Corradini, P
Voena, C
Tarella, C
Astolfi, M
Ladetto, M
Palumbo, A
Van Lint, MT
Bacigalupo, A
Santoro, A
Musso, M
Majolino, I
Boccadoro, M
Pileri, A
Citation: P. Corradini et al., Molecular and clinical remissions in multiple myeloma: Role of autologous and allogeneic transplantation of hematopoietic cells, J CL ONCOL, 17(1), 1999, pp. 208-215
Authors:
Boccadoro, M
Tarella, C
Palumbo, A
Argentino, C
Triolo, S
Dominietto, A
Callea, V
Lauta, VM
Molica, S
Musto, P
Marmont, F
Gianni, AM
Pileri, A
Citation: M. Boccadoro et al., An analysis of which subgroups of multiple myeloma patients, divided according to beta(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy, HAEMATOLOG, 84(10), 1999, pp. 905-910
Authors:
Palumbo, A
Triolo, S
Argentino, C
Bringhen, S
Dominietto, A
Rus, C
Omede, P
Tarella, C
Pileri, A
Boccadoro, M
Citation: A. Palumbo et al., Dose-intensive melphalan with stem cell support (MEL100) is superior to standard treatment in elderly myeloma patients, BLOOD, 94(4), 1999, pp. 1248-1253
Authors:
Massaia, M
Borrione, P
Battaglio, S
Mariani, S
Beggiato, E
Napoli, P
Voena, C
Bianchi, A
Coscia, M
Besostri, B
Peola, S
Stiefel, T
Even, J
Novero, D
Boccadoro, M
Pileri, A
Citation: M. Massaia et al., Idiotype vaccination in human myeloma: Generation of tumor-specific immuneresponses after high-dose chemotherapy, BLOOD, 94(2), 1999, pp. 673-683
Authors:
Boccadoro, M
Citation: M. Boccadoro, Plasma cell disorders: Benign monoclonal gammopathy, solitary plasmocytoma, multiple myeloma and plasma cell leukaemia, TEXTBOOK OF MALIGNANT HAEMATOLOGY, 1999, pp. 609-622
Authors:
Pasquali, S
Maqueo, JD
Vela, J
Kyle, RA
Leong, T
Fritz, E
Suciu, S
Palva, IP
Oivanen, T
Corrado, C
Lastiri, FJ
Peest, D
Kildahl-Andersen, O
Maniatis, A
Alison, R
Clarke, M
Evans, V
Gray, R
Greaves, E
Hall, E
Hicks, C
James, S
Peto, R
Richards, S
Sinclair, D
Tooth, A
Wheatley, K
Avvisati, G
Boccadoro, M
Bugliosi, R
Mandelli, F
Petrucci, MT
Pileri, A
Tribalto, M
Alexanian, R
Delasalle, KB
Child, J
Dunn, J
MacLennan, I
Milligan, D
Mellstedt, H
Osterborg, A
Hjorth, M
Holmberg, E
Rodjer, S
Westin, J
Kamiya, O
Shimizu, K
Bergsagel, DE
Shustik, C
Hippe, E
Kjaersgaard, E
Turesson, I
Westin, J
Riccardi, A
Ucci, G
Blade, J
Fontanillas, M
De Rosa, L
Montuoro, A
Bartolucci, AA
Omura, GA
Stagg, M
Salmon, S
Tangen, C
Jacobs, P
Wood, L
Levy, LM
Citation: S. Pasquali et al., Combination chemotherapy versus melphalan plus prednisone as treatment formultiple myeloma: An overview of 6,633 patients from 27 randomized trials, J CL ONCOL, 16(12), 1998, pp. 3832-3842
Risultati:
1-13
|